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Background/Aim: Muscarinic acetylcholine receptors exist in five subtypes (M1∼M5),
and they are widely expressed in various tissues to mediate diverse autonomic functions,
including gastric secretion. In the present study, we demonstrated, using M1∼M5 KO
mice, the importance of M4 receptors in carbachol (CCh) stimulation of acid secretion
and investigated how the secretion is modulated by the activation of M4 receptors.
Methods: C57BL/6J mice of wild-type (WT) and M1–M5 KO were used. Under urethane
anesthesia, acid secretion was measured in the stomach equipped with an acute fistula.
CCh (30 µg/kg) was given subcutaneously (s.c.) to stimulate acid secretion. Atropine or
octreotide (a somatostatin analog) was given s.c. 20 min before the administration of
CCh. CYN154806 (a somatostatin SST2 receptor antagonist) was given i.p. 20 min
before the administration of octreotide or CCh.
Results: CCh caused an increase of acid secretion in WT mice, and the effect was
totally inhibited by prior administration of atropine. The effect of CCh was similarly
observed in the animals lacking M1, M2 or M5 receptors but significantly decreased
in M3 or M4 KO mice. CYN154806, the SST2 receptor antagonist, dose-dependently
and significantly reversed the decreased acid response to CCh in M4 but not M3
KO mice. Octreotide, the somatostatin analog, inhibited the secretion of acid under
CCh-stimulated conditions in WT mice. The immunohistochemical study showed the
localization of M4 receptors on D cells in the stomach. Serum somatostatin levels in M4
KO mice were higher than WT mice under basal conditions, while those in WT mice
were significantly decreased in response to CCh.
Conclusions: These results suggest that under cholinergic stimulation the acid
secretion is directly mediated by M3 receptors and indirectly modified by M4 receptors.
It is assumed that the activation of M4 receptors inhibits the release of somatostatin from
D cells and minimizes the acid inhibitory effect of somatostatin through SST2 receptors,
resulting in enhancement of the acid response mediated by M3 receptors on parietal
cells.
Keywords: acid secretion, isolated mouse stomach, carbachol, somatostatin, knockout mouse, muscarinic
receptor subtypes, SST2 receptor
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INTRODUCTION
The mechanisms that govern gastric acid secretion involve neuro-
humoral factors, including histamine, gastrin, and acetylcholine
(ACh; Soll, 1994; Hersey and Sachs, 1995; Chen et al., 2004).
The action of histamine is mediated intracellularly by 3′, 5′-
cyclic adenosine monophosphate (cAMP), while those of gastrin
and ACh are mediated by an increase of intracellular Ca2+
(Thurston et al., 1979). The stimulatory actions of histamine
and gastrin are mediated by the activation of histamine H2 and
cholecystokinin (CCK)-2 receptors, respectively (Brimblecombe
et al., 1978; Hersey and Sachs, 1995; Chen et al., 2004),
and that of ACh is caused by the activation of muscarinic
acetylcholine receptors (mAChRs; Soll, 1994; Caulfield and
Birdsall, 1998).
The mAChRs consist of five subtypes (M1–M5) and are widely
expressed in many peripheral organs as well as central nervous
system to mediate diverse autonomic functions, including acid,
pepsin and mucus as well as HCO−3 secretions (Kajimura et al.,
1992; Helander et al., 1996; Caulfield and Birdsall, 1998; Matsui
et al., 2000, 2004; Tobin et al., 2009). These receptors are
G protein-coupled receptors; M1, M3, and M5 receptors are
coupled to Gq protein, while M2 and M4 receptors are coupled
to Gi protein (Caulfield and Birdsall, 1998; Matsui et al., 2000). It
is generally accepted that the acid stimulatory action of carbachol
(CCh), a muscarinic agonist, is mediated by the activation of M1
and M3 receptors (Nakamura et al., 1985; Pfeiffer et al., 1990).
However, Aihara et al. (2005) examined the involvement of M1,
M3, and M5 receptors in cholinergic regulation of acid secretion
using muscarinic receptor knockout (KO) mice and found that
CCh-stimulated acid secretion is mediated by mainly M3 and
partially M5 but not M1 receptors. In addition, we recently found
that CCh-induced duodenal HCO−3 secretion was markedly
decreased in M4 KO mice, suggesting the involvement of M4
receptors in the cholinergic stimulation of HCO−3 secretion
(Takeuchi et al., 2015). However, no information is currently
available on the role of M4 receptors in the cholinergic regulation
of gastric acid secretion.
Somatostatin, a peptide hormone, regulates many
physiological functions in the gastrointestinal tract (Lucey
and Yamada, 1989). This peptide is produced and secreted from
D cells and inhibits acid secretion through a tonic inhibitory
effect on both parietal and enterochromaffin-like cells via the
activation of G protein-coupled SST2 receptors (Warhurst et al.,
1996; Patel, 1997; Piqueras and Martínez, 2004). Chiba and
Yamada (1990) reported that CCh inhibited both basal and
pentagastrin-stimulated somatostatin secretion in the isolated
canine D cells in a Gi protein/cAMP-dependent manner. We
reported the involvement of somatostatin in the regulatory
mechanism of the CCh-stimulated HCO−3 secretion (Takeuchi
et al., 2015). It is thus possible that endogenous somatostatin
may also be involved in the mechanism of gastric acid secretion
in response to cholinergic stimulation, although no study has
tested this hypothesis.
In the present study, we examined the effects of CCh on
gastric acid secretion in wild-type (WT) and mAChR KO mice
lacking M1–M5 receptors, and investigated the involvement of
M4 receptors in the stimulatory action of CCh. We demonstrated
the importance of M4 receptors in the cholinergic stimulation
of gastric acid secretion and showed how this secretion can
be modulated by the activation of M4 receptors, particularly
focusing on the relation to D cell/somatostatin.
MATERIALS AND METHODS
Animals
Age-matched male C57BL/6J mice, weighing 25∼30 g of WT and
those lacking M1, M2, M3, M4, or M5 receptor, were used. The
generation and characterization of each subtype of mAChR KO
mouse strain has been previously described by others (Matsui
et al., 2000; Ohno-Shosaku et al., 2003; Nakamura et al., 2004).
Animals were housed in plastic cages with hardwood chips in
an air-conditioned room (25◦C), and were given standard dry
pellets, CA-1 (CLEA Japan, Tokyo, Japan) and water ad libitum.
All experimental procedures used were carried out in accordance
with the Helsinki Declaration and have been approved by the
Committee for Animal Experimentation established by Kyoto
Pharmaceutical University.
Determination of Gastric Acid Secretion
Acid secretion was measured in acute fistula stomachs of
both WT and M1–M5 KO mice according to a previously
published method (Niida et al., 1991; Kitamura et al., 1999).
Under urethane anesthesia [1.25 g/kg, intraperitoneally (i.p.)],
the trachea was cannulated to ensure a patent airway, and the
body temperature was maintained at 36 ± 1◦C using a heating
lamp. Then, the abdomen was incised, both the stomach and
duodenum were exposed, and the cardiac portion was ligated
without interfering with vagus nerves. An acute fistula (inside
diameter, 2 mm) made with a polyethylene tube was inserted
into the stomach from a small incision made in the duodenum
and held in place by a ligature around the pylorus. At the
beginning of each experiment, the stomach was rinsed several
times with physiological saline (154 mM NaCl) and filled with
0.4 ml of saline for 20 min for determination of the basal
secretion. Then, the stomach was instilled with 0.4 ml of saline,
and the solution was changed every 20 min. The collected
samples were titrated to pH 7.0 against 2 mM NaOH using an
autoburette (Comitite-8; Hiranuma, Tokyo, Japan). Gastric acid
secretion was stimulated by CCh given subcutaneously (s.c.) in
a dose of 30 µg/kg in both WT and KO mice lacking M1–
M5 receptors. In WT mice, atropine (0.1 and 0.3 mg/kg) or
octreotide (a somatostatin analog: 20µg/kg) was given s.c. 20 min
before the administration of CCh. In some cases CYN154806
(a somatostatin SST2 receptor antagonist: 0.1 mg/kg; Feniuk
et al., 2000) was given i.p. 20 min before the administration
of octreotide (20 µg/kg) in WT mice or the administration of
CCh (30 µg/kg) in M4 KO mice. Control animals received saline
or vehicle in place of the active agent. The doses of atropine,
octreotide or CYN154806 were selected in order to induce the
respective pharmacological actions according to the findings of
previously published studies (Aihara et al., 2005; Xie et al., 2005;
Terashima et al., 2009).
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Analyses for Gene Expression of mRNAs
of mAChR Subtypes in Mouse Stomachs
Whole stomachs were collected from both WT mice and those
lacking M1–M5 receptors, and immediately frozen in liquid
nitrogen and stored at−80◦C until use. Total RNA was extracted
from tissue samples using Sepasol RNA I (Nacalai Tesque, Kyoto,
Japan). Total RNA was reverse-transcribed with a first strand
cDNA synthesis kit (ReverTra Ace alpha, TOYOBO, Osaka,
Japan; Amagase et al., 2010). The sequences of the sense and
antisense primers for mouse M1–M5 receptors and GAPDH,
and the sizes of the expected RT-PCR products are shown in
Table 1. An aliquot of the RT reaction product served as a
template in 35 cycles of PCR with 0.5 min of denaturation at
95◦C and 1 min of extension at 68◦C using the Advantage 2
polymerase mixture (CLONTECH, Mountain View, CA, USA) in
a thermal cycler (PC-806, ASTEC, Fukuoka, Japan; Hayashi et al.,
2014). A portion of the PCR mixture was electrophoresed in 1.5%
agarose gel in Tris-acetic acid-EDTA buffer (40 mM Tris, 20 mM
acetic acid, and 2 mM EDTA; pH 8.1), and the gel was stained
with ethidium bromide and photographed (Bio Doc-It Imaging
System; UVP, Upland, CA, USA). Images were analyzed with the
Image J (version 1.39), and the semi-quantitative measurement
of mRNA expression was presented as a ratio compared with
GAPDH (Nakamori et al., 2010; Hayashi et al., 2014).
Immunohistological Study
Expressions of mAChR M4 receptor and somatostatin were
immunohistochemically examined in the gastric mucosa of WT
or M4 KT mice. The stomachs were excised, rinsed with ice-
cold PBS, and embedded in O.C.T. compound (Tissue-Tek,
Sakura, Tokyo, Japan) iced with liquid CO2. Frozen samples were
sectioned at a thickness of 10 µm at −20◦C using a cryostat
microtome (Leica Biosystems CM1510, Nussloch, Germany).
The sections were exposed to 3% bovine serum albumin solution
for 1 h to reduce the non-specific binding of anti-sera. The
sections were exposed to each primary antibody for 16 h at
4◦C, and incubated with the appropriate secondary antibody for
2 h at a room temperature. The sections were mounted with
TABLE 1 | Sequences of sense and antisense primers for mouse M1–M5
receptors.
Sequences PCR
products
Ml sense
antisense
5′-GCAGCAGCTCAGAGAGGTCACAG-3′
5′-GATGAAGGCCAGCAGGATGG-3
413 bp
M2 sense
antisense
5′-GCGGATCCTGTGGCCAACCAAGAC-3′
5′-CGAATTCACGATTTGCGGGCTA-3′
441 bp
M3 sense
antisense
5′-AAGGCACCAAACGCTCATCT-3′
5′-GCAAACCTCTTAGCCAGCGT-3′
511 bp
M4 sense 5′-AGCCGCAGCCGTGTTCACAA-3′ 345 bp
Antisense 5′-TGGGTTGAGGGTTCGTGGCT-3′
M5 sense 5′-GTCTCCGTCATGACCATACTCTA-3′ 230 bp
Antisense 5′-CCCGTTGTTGAGGTGCTTCTAC-3′
GAPDH sense 5′-GAACGGGAAGCTCACTGGCATGGC-3′ 191 bp
antisense 5′-TGAGGTCCACCACCCTGTTGCTG-3′
VECTASHIELD mounting medium, including 4,6-diamidino-
2- phenylindole (Vector Laboratories, Peterborough, UK). The
preparations were observed using a fluorescence microscope
(Olympus BX51, Tokyo, Japan) and photographed using an
Olympus digital camera. The following primary antibodies
were used: rabbit anti-mAChR M4 and goat anti-Somatostatin
(Santa Cruz Biotechnology, Santa Cruz, CA, USA). Alexa Fluor
488 conjugated donkey anti-rabbit IgG and Alexa Fluor 546
conjugated donkey anti-goat IgG (Molecular Probes, Eugene,
OR, USA) were used as secondary antibodies.
Determination of Serum Somatostatin
Levels
Serum levels of somatostatin were measured in both WT and
M4 KO mice before and after the s.c. administration of CCh
(30µg/kg), according to a previously published paper (Terashima
et al., 2009). Thirty minutes after each treatment, blood was
collected from the descending aorta. Then, blood samples were
centrifuged at 6000 g for 15 min, and the supernatant of
each sample was frozen at 20◦C until the measurement of
somatostatin. The concentration of somatostatin was measured
with a somatostatin immunoassay kit (Peninsula Laboratories,
Inc., San Carlos, CA, USA).
Preparation of Drugs
Drugs used were urethane (Tokyo Kasei, Tokyo, Japan),
carbamylcholine chloride [carbachol: CCh], octreotide,
CYN154806 (Sigma-Aldrich, St. Louis, MO, USA), and atropine
sulfate (Nacalai tesque, Kyoto, Japan). CCh and atropine were
dissolved in saline, while octreotide and CYN154806 were
dissolved in dimethyl sulfoxide (DMSO: Wako, Osaka, Japan)
and diluted with distilled water to desired concentrations. Each
agent was prepared immediately before use and administered as
a single injection s.c. or i.p. in a volume of 1 ml per 100 g body
weight.
Statistical Analysis
Data are presented as means ± SE. Differences between two
groups were evaluated with the Student’s t-test. Differences
between multiple groups were evaluated with analysis of variance
followed, when necessary, by a Dunnett’s multiple comparison
test. Values of P < 0.05 were considered statistically significant.
RESULTS
Effect of CCh on Gastric Acid Secretion
in WT Mice
Under urethane anesthesia the stomachs of WT mice
spontaneously secreted acid secretion in almost negligible
amount of less than 0.1–0.2 µmol/20 min. Subcutaneously
administered CCh (30 µg/kg) significantly stimulated
acid secretion; the acid secretion reached a peak value of
3.8 ± 0.5 µmol/20 min 20 min after the administration,
followed by a gradual decrease to near basal levels 100 min later
(Figure 1A). Pretreatment of the animals with atropine (0.1
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FIGURE 1 | Effects of atropine on CCh-stimulated acid secretion in the stomach of WT mice. CCh (30 µg/kg) was administered s.c. as a single injection.
Atropine (0.1 and 0.3 mg/kg) was given s.c. 20 min before the administration of CCh. (A) Data are presented as the mean ± SE of values determined every 20 min
from six mice. (B) Shows the total net acid output for 2 h after the administration of CCh, and the data are presented as the mean ± SE from six mice. Significant
difference at P < 0.05; ∗ from control; # from Vehicle.
FIGURE 2 | Effects of CCh on acid secretion in the stomachs of WT
mice and those of KO animals lacking M1–M5 receptors. CCh
(30 µg/kg) was administered s.c. as a single injection. Data show the total net
acid output for 2 h after the administration of CCh and are presented as the
mean ± SE from six mice. ∗Significant difference from WT at p < 0.05.
and 0.3 mg/kg, s.c.) dose-dependently inhibited the increase
of acid secretion in response to CCh, and the net acid output
at 0.1 and 0.3 mg/kg was 2.8 ± 0.3 and 0.3 ± 0.1 µmol/2 h,
respectively, both of which were significantly lower than that
(7.9 ± 1.3 µmol/2 h) of control mice given CCh plus vehicle
(Figures 1A,B).
Effect of CCh on Gastric Acid Secretion
in mAChR KO Mice
Since the acid stimulatory action of CCh was almost completely
inhibited by atropine, the non-selective antagonist of mAChR,
these results confirmed that CCh stimulated gastric acid secretion
via the activation of mAChRs. We then investigated the
subtype(s) of mAChRs involved in the regulation of gastric acid
secretion, we examined the effects of CCh on acid secretion in the
stomachs of mAChR KO mice lacking M1, M2, M3, M4, or M5
receptors.
The stomachs of both WT and various mAChR KO mice
consistently secreted 0.1∼0.3 µmol/20 min of H+ as basal
secretion, and no significant difference was observed in the
basal rates of the stomachs of these animals (data not shown).
The stimulatory action of CCh (30 µg/kg, s.c.) was similar
between mAChR KO mice lacking M1 and M2 receptors and WT
mice, with the net acid outputs being 8.0 ± 0.8 µmol/2 h and
6.8 ± 0.9 µmol/2 h, respectively, which were almost equivalent
to that (8.1 ± 0.7 µmol/2 h) in WT mice (Figure 2). Although
a slight decrease in the acid response to CCh was observed in
M5 KO mice, the net acid output (6.4 ± 0.7 µmol/2 h) was not
statistically significant from that of WT mice. In contrast, the
acid response to CCh was significantly decreased in M3 and M4
KO mice, with the net acid outputs being 2.3 ± 0.9 µmol/2 h
and 2.1 ± 0.5 µmol/2 h, respectively. As shown in Figure 3A,
CCh-stimulated acid secretion was markedly decreased in M4
KO mice. In WT mice the secretion of acid reached a peak
value of 4.7 ± 0.7 µmol/20 min with the net acid output being
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FIGURE 3 | Effects of CCh on acid secretion in the stomachs of WT and M4 KO mice. CCh (30 µg/kg) was administered s.c. as a single injection. (A) The
data are presented as the mean ± SE of values determined every 20 min from nine mice. (B) Shows the total net acid output for 2 h after the administration of CCh,
and the data are presented as the mean ± SE from nine mice. Significant difference at p < 0.05; ∗ from Saline in WT; # from CCh in WT.
8.5 ± 1.2 µmol/2 h, while in M4 KO mice the peak value
was 1.0 ± 0.2 µmol/20 min with the net acid output being
1.8 ± 0.3 µmol/2 h, which was significantly lower than that in
WT mice (Figure 3B).
Effects of Somatostatin on Gastric Acid
Secretion in WT Mice
Somatostatin has been shown to inhibit secretory and motor
functions in the gastrointestinal tract and antagonizes the actions
of several hormones (Lucey and Yamada, 1989; Piqueras and
Martínez, 2004; Takeuchi et al., 2015). Since the release of
somatostatin from D cells is known to be mediated by an increase
in cAMP (Lucey and Yamada, 1989), and the activation of M4
receptors is coupled with Gi protein to inhibit adenylate cyclase
(Caulfield and Birdsall, 1998; Tobin et al., 2009), it is possible
that the decreased acid response observed in M4 KO mice may
be associated with changes in somatostatin secretion. Therefore,
we examined the effects of octreotide, an analog of somatostatin,
on gastric acid secretion in WT mice under CCh-stimulated
conditions.
The basal secretion of acid in WT mice was very scanty
with less than 0.1∼2 µmol/20 min and did not show
significant changes following the s.c. administration of octreotide
(20 µg/kg). However, the gastric acid response induced by CCh
(30 µg/kg) was markedly reduced by the prior administration of
octreotide; the net acid output was 0.7 ± 0.6 µmol/2 h, which
was highly significantly different from that (8.5 ± 1.9 µmol/2 h)
of WT mice (Figures 4A,B). This inhibitory effect of octreotide
was completely abrogated when CYN154806 (0.1 mg/kg), a
SST2 antagonist, was given 20 min before the administration
of octreotide; the net acid output in response to CCh was
9.5 ± 0.8 µmol/2 h, which was almost equivalent to that of WT
mice.
Effects of the Somatostatin SST2
Receptor Antagonist CYN154806 on
Gastric Acid Response to CCh in M4 KO
Mice
We demonstrated that octreotide, an exogenous somatostatin
analog, significantly inhibited CCh-stimulated secretion of acid
in the stomachs of WT mice. Since it has been shown that CCh
inhibited both basal and pentagastrin-stimulated somatostatin
secretion in rats (Chiba and Yamada, 1990), there may be
some interaction between somatostatin secretion and CCh-
stimulated acid secretion. Then, to investigate the involvement of
endogenous somatostatin in the decreased acid response to CCh
in M4 KO mice, we examined the effects of CYN154806, a SST2
receptor antagonist, on the CCh-stimulated acid secretion in M4
KO mice.
Subcutaneously administered CCh (30 µg/kg) markedly
increased acid secretion in the stomachs of WT mice, the
peak value of acid secretion was 4.2 ± 0.2 µmol/20 min and
the net acid output was 8.2 ± 1.3 µmol/2 h (Figures 5A,B).
By contrast, CCh did not increase acid secretion in the
stomachs of M4 KO mice; the peak value of acid secretion
was 0.9 ± 0.1 µmol/20 min, while the net acid output was
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FIGURE 4 | Effects of octreotide on CCh-stimulated acid secretion in the stomachs of WT mice. CCh (30 µg/kg) was administered s.c. as a single
injection. Octreotide (20 µg/kg), an analog of somatostatin-14, was administered s.c. 20 min before the administration of CCh, while CYN154806 (0.1 mg/kg), a
SST2 antagonist, was given i.p. 20 min before the administration of octreotide. (A) The data are presented as the mean ± SE of values determined every 20 min
from 5 to 6 mice. (B) Shows the total net acid output for 2 h after the administration of CCh, and the data are presented as the mean ± SE from 5 to 6 mice.
Significant difference at P < 0.05; ∗ from Control (saline); # from Vehicle + CCh; $ from Vehicle + Octreotide + CCh.
FIGURE 5 | Effects of CCh on acid secretion in the stomachs of WT and M4 KO mice, with or without the pretreatment of CYN154806. CCh (30 µg/kg)
was administered s.c. as a single injection. CYN154806 (0.1 mg/kg) was administered i.p. 20 min before the administration of CCh. (A) The data are presented as
the mean ± SE of values determined every 20 min from 4 to 11 mice. Significant difference at p < 0.05, ∗ from Saline (WT), # from CCh (WT), $ from Vehicle + CCh
(M4KO). (B) Shows the total net acid output for 2 h after the administration of CCh, and the data are presented as the mean ± SE of values determined every 10 min
from 4 to 11 mice. Significant difference at p < 0.05, ∗ from CCh (WT), # from Vehicle + CCh (M4 KO).
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FIGURE 6 | Fluorescence immunochemical staining of the gastric mucosa with anti-somatostatin and anti-M4 receptor antibodies in WT or M4 KO
mice. Somatostatin was stained red, while M4 receptor was stained green. The left of the lower panels shows higher magnification to indicate the co-expression of
M4 receptors with somatostatin on D cells in a WT mouse stomach as visualized as yellow in the merged image. In the right of the lower panels showed that M4
receptors were not observed in the gastric mucosa of a M4 KO mouse.
1.0 ± 0.8 µmol/2 h, which was almost equivalent to that in
the stomachs of M4 KO treated with saline. However, when M4
KO mice were pretreated i.p. with CYN154806 (0.1 mg/kg), the
administration of CCh potently increased acid secretion; the peak
value was 5.1 ± 0.3 µmol/20 min, while the net acid output
was 10.1 ± 2.5 µmol/2 h, which was significantly greater than
that of M4 KO mice without pretreatment of CYN154806. The
decreased acid response to CCh in M3 KO mice was not affected
by CYN154806 (data not shown).
Immunostaining of Somatostatin and M4
Receptors in Stomach of WT and M4 KO
Mice
To examine the presence of M4 receptors in D cells, we
performed the immunostaining of the gastric mucosa with
anti-somatostatin and anti-M4 receptor antibodies in WT
mice. As expected, the expression of somatostatin was clearly
observed in the stomach of WT mouse; it was stained
red (Figure 6). On the other hand, the immunostaining of
M4 receptors was also observed in the same area of the
stomach; the higher magnification showed the co-existence of
M4 receptors with somatostatin (a left figure of the lower
panel), suggesting the expression of M4 receptors on D
cells. No expression of M4 receptors was detected in the
stomach of M4 KO mouse (a right figure of the lower
panel), although the immunostaining of somatostatin was
observed in this animal similar to WT mouse (data not
shown).
Changes in Serum Levels of
Somatostatin after Administration of
CCh in WT and M4 KO Mice
Serum levels of somatostatin in WT mice under urethane
anesthesia were 0.33 ± 0.04 ng/ml. The levels of somatostatin
in M4 KO mice were slightly higher (0.40 ± 0.04 ng/ml) than
those in WT mice, although the difference was not statistically
significant (Figure 7). On the other hand, the serum levels
in WT mice were slightly but significantly decreased after
the s.c. administration of CCh (30 µg/kg), the values being
0.22 ± 0.01 ng/ml. By contrast, the administration of CCh in
M4 KO mice markedly increased the levels of somatostatin
to 0.57 ± 0.04 ng/ml, the values being significantly higher
than those in WT mice or those in M4 KO administered
vehicle.
Gene Expressions of mAChR Subtypes in
Mouse Stomachs
Since it was found that both M3 and M4 receptors were involved
in the stimulatory action of CCh on gastric acid secretion, we
examined the gene expressions of mAChR subtypes, M1–M5, in
the mouse stomach. The expressions of M1–M5 mRNAs were
all observed in the stomachs of WT mice, though the intensity
slightly differed depending on the subtypes (Figure 8). The
expressions of mAChRs were also observed in the stomachs of
KO mice lacking M1–M5 receptors, except lacking a respective
mAChR subtype in the corresponding KO mice.
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FIGURE 7 | Changes in serum somatostatin levels in WT or M4 KO
mice after the administration of CCh. CCh (30 µg/kg) was administered
s.c. as a single injection. Data are presented as the means ± SE for 5 to 6
mice. Significant difference at P < 0.05; ∗ from WT; # from vehicle.
FIGURE 8 | Gene expressions of mAChR subtypes (M1–M5) in the
mouse stomach. Note that a respective mAChR subtype was lacking in the
corresponding KO mice lacking M1–M5 receptors in the stomach.
DISCUSSION
The parietal cell, which is responsible for gastric acid secretion,
is known to express histamine H2 receptor and CCK2 receptors
in addition to M3 receptors (Pfeiffer et al., 1990; Kajimura
et al., 1992; Soll, 1994; Chen et al., 2004). The secretion of
acid stimulated by Histamine or gastrin is mediated by the
former two receptors, respectively (Brimblecombe et al., 1978;
Soll, 1994; Chen et al., 2004), while the subtypes of mAChRs
responsible for cholinergic stimulation of acid secretion remains
fully unexplored (Nakamura et al., 1985; Pfeiffer et al., 1990;
Matsui et al., 2004; Aihara et al., 2005). The mechanism of
cholinergic stimulation of acid secretion has been thought to
involve M1 and M3 receptors (Nakamura et al., 1985; Pfeiffer
et al., 1990), yet a recent study reported that gastric acid secretion
was normally stimulated by histamine and gastrin as well as CCh
in M1 KO mice, suggesting that M1 receptors are not involved
in the regulation of gastric acid secretion in mice (Aihara et al.,
2005). In the present study, we demonstrated for the first time
the involvement of muscarinic M4 receptors in the regulatory
mechanism of cholinergic stimulation of gastric acid secretion.
The mAChRs, consisting of five subtypes (M1–M5), are
widely expressed in many peripheral organs to include the
gastrointestinal tract (Kajimura et al., 1992; Helander et al., 1996;
Matsui et al., 2000; Tobin et al., 2009). In the present study,
we confirmed by RT-PCR analysis that all mAChR subtypes
including M1–M5 were expressed in the mouse stomach,
although the degree of expression differed depending on the
subtype; M3 and M4 receptors were potently expressed while
M1, M2, and M5 were expressed weakly. In addition, we
also demonstrated that the expressions of mAChRs were also
observed in the stomachs of KO mice lacking M1–M5 receptors,
except lacking a respective mAChR subtype in the corresponding
KO mice. Others reported the expression of M1 receptors on
zymogen cells and surface mucosal cells (Xie et al., 2005), that of
M3 receptors on parietal cells (Pfeiffer et al., 1990; Kajimura et al.,
1992; Aihara et al., 2005), and those of M2 and M4 receptors on
D cell (Sachs et al., 1997; Takeuchi et al., 2015).
We found that CCh, a muscarinic agonist, dose-dependently
increased acid secretion in the stomach of WT mice, and
this response was almost completely inhibited by the prior
administration of atropine, confirming the mediation of this
secretion by the activation of mAChR. Cholinergic stimulation
of gastric acid secretion is thought to involve M1 receptors in
addition to M3 receptors, because acid secretion was inhibited by
pirenzepine, a selective M1 receptor antagonist (Nakamura et al.,
1985). However, Aihara et al. (2005) examined the involvement
of M1, M3, and M5 receptors in cholinergic regulation of acid
secretion using muscarinic receptor KO mice and found that
CCh-stimulated acid secretion is mediated by mainly M3 and
partially M5 but not M1 receptors. They also demonstrated
that pirenzepine exhibited similar inhibitory effects on CCh-
stimulated acid secretion in both WT and M1 KO mice,
suggesting that inhibition of acid secretion by pirenzepine is
unlikely to result from M1-receptor blockade (2005). On the
other hand, M5 receptors might be expressed in the enteric
nervous system and mediates cholinergic stimulation of acid
secretion by increasing Ach release from nerve endings and/or
releasing histamine from enterochromaffin-like cells (Aihara
et al., 2005).
In the present study, we found using KO mice lacking M1–
M5 receptors that CCh stimulated acid secretion in M1, M2,
and M5 KO animals as effectively as in WT mice, but the
stimulatory effect was markedly attenuated in M3, and M4 KO
mice. We observed a slight decrease in the acid response to CCh
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in M5 KO mice, but the net acid output was not significantly
different from that of WT mice. The reason for the different
results between the study of Aihara et al. (2005) and our study,
it may be due to different methods for acid measurement; they
measure acid secretion in pylorus-ligated technique while we
measured the secretion in the stomach with an acute fistula.
Anyhow, it is therefore assumed that the cholinergic stimulation
of gastric acid secretion is mediated by the activation of M3, and
M4 receptors. In particular, the present study demonstrated for
the first time the involvement of M4 receptors in the process
of the CCh-stimulated gastric acid secretion, in addition to M3
receptors.
M3 receptors are coupled to Gq/11 protein to increase
intracellular Ca2+ that mediates the secretion of acid as well as
many hormones (Warhurst et al., 1996). Since acid secretion in
response to CCh is known to be attenuated by a Ca2+ channel
blocker, it is reasonable that M3 receptors are involved in the
process of cholinergic stimulation of acid response (Pfeiffer et al.,
1990; Aihara et al., 2005). It remains, however, unknown how
the activation of M4 receptors modulates the acid response to
CCh in the stomach. Since M4 receptors are coupled to Gi
protein to decrease intracellular cAMP production (Caulfield and
Birdsall, 1998), and since stimulation of gastric acid secretion is
intracellularly mediated by cAMP, in addition to Ca2+ (Thurston
et al., 1979; Soll, 1994; Hersey and Sachs, 1995), it is unlikely that
M4 receptors are expressed in parietal cells and directly mediate
the stimulation of acid secretion in response to CCh. Therefore,
it is assumed that M4 receptors are expressed in cells other than
parietal cells and indirectly affect the acid response to cholinergic
stimulation.
By the way, somatostatin is synthesized in a variety of organs
of the mammalian body and exerts almost ubiquitously an
inhibitory action against various physiological processes (Lucey
and Yamada, 1989). In the gastrointestinal tract, this peptide
has been shown to inhibit motility and secretory functions
and antagonizes the actions of several hormones (Lucey and
Yamada, 1989; Warhurst et al., 1996; Terashima et al., 2009).
Chiba and Yamada (1990) reported that CCh inhibited both
basal and pentagastrin- stimulated somatostatin secretion in a
Gi protein/cAMP-dependent manner in the isolated canine D
cells. Five subtypes, SST1-SST5, of somatostatin receptors are
currently known to exist, and all of them are expressed in the
gastrointestinal tract (Chiba and Yamada, 1990; Krempels et al.,
1997; Patel, 1997). It is thus possible that the activation of M4
receptors inhibits somatostatin secretion from D cells and by
so doing indirectly affect acid secretion. If this is the case, the
followings should be demonstrated; (i) somatostatin suppresses
the acid response to cholinergic stimulation such as CCh, (ii)
the decreased acid response in M4 KO mice can be reversed by
the SST2 antagonist, and (iii) the release of somatostatin from
D cells is increased in M4 KO mice. As expected, we found
that CCh-stimulated acid secretion was significantly suppressed
by octreotide, the somatostatin analog. We also found that
the suppressed acid response to CCh in M4 KO mice was
significantly restored by the prior application of the somatostatin
SST2 antagonist, CYN154806. In addition, it was found that
serum somatostatin levels were significantly increased in M4 KO
FIGURE 9 | Working hypothesis for the involvement of M4 receptors in
the regulatory mechanism of cholinergic stimulation of gastric acid
secretion. The cholinergic stimulation of acid secretion is mediated by the
activation of M3 and M4 receptors. The activation of M3 receptors directly
affects acid secretion from the parietal cells through a Gq protein/Ca2+
pathway, while the activation of M4 receptors inhibits somatostatin secretion
from D cells and by so doing unmasks the stimulatory effect of CCh mediated
by the activation of M3 receptors in the parietal cells.
mice under CCh-stimulated conditions. These results strongly
support our hypothesis that the decrease of CCh-induced acid
response in M4 KO mice is explained by the inhibitory effect
of somatostatin mediated by SST2 receptors. It is therefore
assumed that the activation of M4 receptors inhibits somatostatin
release from D cells and negates the negative influence of this
peptide on acid secretion, resulting in a potentiation of the acid
response to CCh. Certainly, more studies are needed to clarify
the regulatory mechanisms of somatostatin secretion from D
cells.
Finally, it remains undefined whether M4 receptors are really
expressed on D cells? We performed the immunostaining of
the gastric mucosa with anti-somatostatin and anti-M4 receptor
antibodies in WT mice. The histological observation showed that
M4 receptors were co-expressed with somatostatin, indicating the
expression of M4 receptors on D cells. We confirmed that M4
receptors were not observed in the stomachs of M4 KO mice.
These results strongly suggest that CCh inhibits somatostatin
release from D cells via the activation of M4 receptors. The
present study was performed in mice anesthetized with urethane.
Since this anesthetic is known to promote the secretion of
somatostatin from D cells (Saito et al., 1979), the results obtained
in this study might differ from those obtained under normal
physiological conditions. However, since CYN154806 by itself
had no effect on basal acid secretion, it is assumed that the
interpretation of the present results is not affected by urethane
anesthesia.
Given the findings of the present study, we conclude that the
cholinergic stimulation of gastric acid secretion is mediated by
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the activation of M3 receptors in parietal cells and modified
indirectly by M4 receptors in D cells (Figure 9). It is assumed that
the activation of M4 receptors inhibits the release of somatostatin
from D cells to result in enhancement of the acid response by
removing the negative influence of somatostatin via the activation
of SST2 receptors.
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